PERSONAL INFORMATION Khaled EZZEDINE

Université Paris Est Créteil (UPEC) and University Hospital Henri Mondor, Department of Dermatology, 51 Avenue du Maréchal de Lattre de Tassigny, 94010 Créteil, France +33 6 65 37 70 45

khaled.ezzedine@aphp.fr

Sex M | Date of birth 18/06/1967 | Nationality France

EDUCATION AND TRAINING

1998: MD, Dakar, Senegal 2004: Qualified in Dermatology, Brussels, Belgium 2005: Master of sciences in Biology and Heath, Bordeaux, France 2006-2008: PhD in Epidemiology, Paris, France 2013: Accreditation to supervise research, Bordeaux, France

WORK EXPERIENCE

2000-2004: Intern, University Hospital Center ERASME, Université Libre de Bruxelles, Brussels,

Belgium 2005-2006: Resident, University Hospital Center Erasme, Université Libre de Bruxelles, Brussels,

Belgium 2006-2008: Applicant researcher at the U557 Inserm (UMR Inserm/Inra/Cnam/Paris 13) et Unité de

Surveillance et d'Epidémiologie Nutritionnelle (USEN, InVS/Cnam/Paris13), Centre de Recherche en Nutrition Humaine Ile-de-France, SMBH Paris 13 (Director, Pr Serge Hercberg).

2008-2015: Senior physician, Department of Dermatology, University Hospital Centre St-André,

Bordeaux, France 2008-2015: Associate Professor of Dermatology, University Victor Segalen Bordeaux 2, Bordeaux,

France and Vice-Director of the National Reference Center for Rare Skin Diseases of Bordeaux, Responsible for epidemiological research

Since 2008: Lead of the skin Group in the French national cohorts NUTRINET and SUVIMAX 2015: Elected Professor of Dermatology, Department of Dermatology University Hospital Henri

Mondor and Université Paris Est Créteil (UPEC)

REFERENCED PUBLICATIONS (SELECTION OF 10 MOST SIGNIFICANT PUBLICATIONS)

1. Prey S, Voisard JJ, DelarueA, Lebbé G, Taieb A, Léauté-Labrèze C, Ezzedine K. Safety of propranolol therapy for severe infantile hemangiomas. JAMA 2016; 315(4):413-5. (IF: 35.3, Rang SIGAPS A).

2. Ezzedine K, Whitton M, Pinart M. Interventions for vitiligo. JAMA 2016; 316: 1708-1709. (IF:

37.684, Rang SIGAPS A) 3. Gan EY, Cario-André M, Pain C, Goussot JF, Taieb A, Seneschal J, Ezzedine K. Follicular vitiligo:

A report of 8 cases. J Am Acad Dermatol 2016 (in press) (IF: 5.661, Rang SIGAPS A).

4. Salzes C, Abadie S, Seneschal J, Whitton M, Meurant JM, Jouary T, Ballanger F, Boralevi F, Taieb A, Taieb C, Ezzedine K. The Vitiligo Impact Patient scale (VIPs): development and validation of a vitiligo burden assessment tool. J Invest Dermatol 2016; 136: 52-8 (IF: 7.216, Rang SIGAPS A).

5. Touvier M, Deschaseaux M, Monturcy M, Sutton N, Charnaux N, Kesse-Guyot E, Assman K, Fezeu L, Latino-Martel P, Druesne-Pecollo N, Guinot C, Malvy D, Latreille J, Galan P, Hercberg S, Leclerc S, Souberbielle JC, Ezzedine K. Determinants of 25OHD status in Caucasian adults:

influence of sun exposure, dietary vitamin D intake, socio-demographic, lifestyle, anthropometric and genetic factors. J Invest Dermatol 2015; 135: 378-88 (IF: 7.216, Rang SIGAPS A).

6. Ezzedine K, Eleftheriadou V, Whitton M, Nan Geel N. Vitiligo. Lancet 2015; 386: 74-84. (IF:

45.217, Rang SIGAPS A). 7. Ezzedine K *, Dutkiewicz AD*, Mazereeuw-Hautier J, Lacour JP, Barbarot S, Vabres P, Miquel J,

Balguerie V, Martin L, Boralevi F, Bessou P, Chateil JF, Léauté-Labrèze C. On behalf of the Groupe de Recherche Clinique en Dermatologie Pédiatrique. A prospective study of risk factors for leptomeningeal angiomata in children with upper facial port-wine stain. J Am Acad Dermatol 2015; 72: 473-80 (IF: 4.449, Rang SIGAPS A). (*Equally contributor)

8. Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, González U, Jiyad Z, Eleftheriadou V, Ezzedine K. Interventions for vitiligo. Cochrane Database Syst Rev 2015; 2:CD003263 (IF:

Page 2 / 12

6.032, Rang SIGAPS A). 9. Ezzedine K, le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent Class Analysis of

a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma res 2014; 27: 134-9 (IF: 4.619, Rang SIGAPS B). 10. Diallo A, Boniface K, Jouary T, Seneschal J, Morice-Picard F, Prey S, Cario-André M, Mazereeuw-Hautier J, Taieb A, Ezzedine K. Development and validation of the K-VSCOR for

scoring Koebner’s phenomenon in Vitiligo/non-segmental vitiligo. Pigment Cell Melanoma res 2013; 26: 402-7 (IF: 4.619, Rang SIGAPS B).

REFERENCED PUBLICATIONS (ORIGINAL ARTICLES AND RESEARCH LETTERS)

1. Phan C, Ezzedine K, Lai C, Le Cleach L, Cogrel O, Fardet L, Wolkenstein P, Chosidow O,

Beylot Barry M, Sbidian E. Validation of self-diagnostic questionnaires for inflammatory skin disorders. Acta Derm Venereol 2017 (in press).

2. Jacquemin C, Rambert J, Guillet S, Thiolat D, Boukhedouni N, Doutre MS, Darrigade AS, Ezzedine K, Blanco P, Taieb A, Boniface K, Seneschal J. HSP70 potentiates interferon-

alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis. Br J Dermatol 2017 (in press)

3. van Geel N, Boniface K, Seneschal J, Jacquemin C, Speeckaert R, Wolkerstorfer A, Bekkenk M, Lommerts JE, Hamzavi I, Pandya A, Eleftheriadou V, Ezzedine K, Giannarelli

D, Gnarra M, Sperduti I, Prinsen C, Harris J, Taieb A, Picardo M. Meeting report: Vitiligo Global Issues Consensus Conference (VGICC) Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3rd. Pigment Cell Melanoma Res 2017 (in press)

4. Saurat JH, Mengeaud V, Georgescu V, Coutanceau C, Ezzedine K, Taieb C. A simple self-

diagnosis tool to assess the prevalence of dermatoporosis in France. J Eur Acad Dermatol Venereol 2017 (in press). (IF: 3.029, Rang SIGAPS B).

5. Darrigade AS, Milpied B, Truchetet ME, Schaeverbeke T, Laharie D, Zerbib F, Beylot-Barry M, Jouary T, Taïeb A, Ezzedine K, Seneschal J. Pattern and Severity of Psoriasiform

Eruptions in Patients with Inflammatory Bowel Diseases, Arthritis or Skin Inflammatory Disorders Treated with TNF alpha Inhibitors. Acta Derm Venereol 2017 (in press); doi: 10.2340/00015555-2636.

6. van Geel N, Lommerts JE, Bekkenk MW, Prinsen CA, Eleftheriadou V, Taieb A, Picardo M, Ezzedine K, Wolkerstorfer A, Speeckaert R; international Vitiligo Score Working Group.

Development and validation of a patient-reported outcome measure in vitiligo: The Self Assessment Vitiligo Extent Score (SA-VES). J Am Acad Dermatol 2017; 76: 464-471. (IF: 5.621, Rang SIGAPS A).

7. Gan EY, Eleftheriadou V, Esmat S, Hamzavi I, Passeron T, Böhm M, Anbar T, Goh BK, Lan CE, Lui H, Ramam M, Raboobee N, Katayama I, Suzuki T, Parsad D, Seth V, Lim HW, van Geel N, Mulekar S, Harris J, Wittal R, Benzekri L, Gauthier Y, Kumarasinghe P, Thng ST, Silva de Castro CC, Abdallah M, Vrijman C, Bekkenk M, Seneschal J, Pandya AG, Ezzedine K, Picardo M, Taïeb A; on behalf of the VGICC. Repigmentation in vitiligo: position

paper of the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res 2017; 30: 28-40. (IF: 4.163, Rang SIGAPS B).

8. Lommerts JE, Teulings HE, Ezzedine K, Van Geel N, Hartmann A, Speeckaert R, Spuls PI,

Wolkerstorfer A, Luiten R, Bekkenk MW. Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field. J Am Acad Dermatol 2016; 75: 1198-1204. (IF: 5.621, Rang SIGAPS A).

9. Deschasaux M, Souberbielle JC, Partula V, Lécuyer L, Gonzalez R, Srour B, Guinot C, Malvy D, Latino-Martel P, Druesne-Pecollo N, Galan P, Hercberg S, Kesse-Guyot E, Fassier P, Touvier M*, Ezzedine K*. What Do People Know and Believe about Vitamin D? Nutrients.

2016; 8: pii: E718. (IF: 3.759, Rang SIGAPS B). (*Equally contributing) 10. Banner A, Dinsey M, Ezzedine K, Dadzie OE. The Spectrum of Skin Diseases Occurring in

a Multi-Ethnic Population in Northwest London, UK; Findings of a Cross-Sectional Descriptive Study. Br J Dermatol 2016 (In press). (IF: 4.317, Rang SIGAPS A).

11. Mermin D, Boursault L, Milpied B, Taieb A, Ezzedine K, Seneschal J. DLQI as a major

criterion for introduction of systemic agents in patients with mild psoriasis. J Eur Acad Dermatol Venereol 2016; 30: 1961-1964. (IF: 3.029, Rang SIGAPS B).

12. Laville V, Le Clerc S, Ezzedine K, Jdid R, Taing L, Labib T, Coulonges C, Ulveling D,

Carpentier W, Galan P, Hercberg S, Morizot F, Latreille J, Malvy D, Tschachler E, Zagury JF. A Genome-Wide Association Study in Caucasian Women suggests the involvement of HLA genes in the severity of facial solar lentigines. Pigment Cell Melanoma Res 2016; 29: 550-8. (IF: 4.163, Rang SIGAPS B).

13. Ezzedine K, Whitton M, Pinart M. Interventions for vitiligo. JAMA 2016; 316: 1708-1709. (IF:

37.684, Rang SIGAPS A) 14. Jin Y, Andersen G, Yorgov D, Ferrara TM, Ben S, Brownson KM, Holland PJ, Birlea SA,

Siebert J, Hartmann A, Lienert A, van Geel N, Lambert J, Luiten RM, Wolkerstorfer A,

Wietze van der Veen JP, Bennett DC, Taïeb A, Ezzedine K, Kemp EH, Gawkrodger DJ,

Weetman AP, Kõks S, Prans E, Kingo K, Karelson M, Wallace MR, McCormack WT, Overbeck A, Moretti S, Colucci R, Picardo M, Silverberg NB, Olsson M, Valle Y, Korobko I, Böhm M, Lim HW, Hamzavi I, Zhou L, Mi QS, Fain PR, Santorico SA, Spritz RA. Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nat Genet 2016; 48: 1418-1424. (IF: 31.616, Rang SIGAPS A).

15. Gan EY, Gahat T, Cario-André M, Seneschal J, Ezzedine K, Taïeb A. Clinical repigmentation

patterns in Pediatric vitiligo. Br J Dermatol 2016; 175: 555-60. (IF: 4.317, Rang SIGAPS A). 16. Deschasaux M, Souberbielle JC, Sutton A, Charnaux N, Kesse-Guyot E, Latino-Martel P,

Druesne-Pecollo N, Szabo de Edenleyi F, Galan P, Hercberg S, Touvier M*, Ezzedine K*.

Quick and easy screening for vitamin D insufficiency in adults: a scoring system to be implemented in daily clinical practice. Medicine 2016; 95: e2783. (*Equally contibutor)

17. Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M. A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk. Br J Nutr 2016 115: 305-14 (IF: 3.453, Rang SIGAPS B).

18. Vergier B, Elodie Laharanne, Prochazkova-Carlotti M, de la Fouchardière A, Merlio JP, Avril MF, Bodemer C, Lacoste C, Boralevi F, Taieb A, Ezzedine K, Fraitag S. Proliferative

Nodules versus Melanoma arising in Giant Congenital Melanocytic Nevi during childhood. JAMA Dermatol 2016 (in press) (IF: 4.6, Rang SIGAPS A).

19. Gan EY, Cario-André M, Pain C, Goussot JF, Taieb A, Seneschal J, Ezzedine K. Follicular vitiligo: A report of 8 cases. J Am Acad Dermatol 2016 (in press) (IF: 5.661, Rang SIGAPS

A). 20. Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo

N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M. Weight status and alcohol intake modify the association between vitamin D and breast cancer risk". J Nutr

2016 (in press) (IF: 3.875, Rang SIGAPS B). 21. Whitton M, Pinart M, Batchelor JM, Leonardi-Bee J, Gonzalez U, Jiyad Z, Eleftheriadou V,

Ezzedine K. Evidence-Based Management of vitiligo: summary of a Cochrane systematic review. Br J Dermatol 2016 (in press) doi: 10.1111/bjd.14356 (IF: 4.275, Rang SIGAPS A).

22. Van Geel N, Loomerts J, Bekkenk M, Wolkerstorfer A, Prinsen S, Eleftheriadou V, Taieb A, Picardo M, Ezzedine K, Speekhaert R. Development and validation of the Vitiligo Extent Score (VES): an international collaborative initiative. J Invest Dermatol 2015 (in press). (IF: 7.216, Rang SIGAPS A).

23. Prey S, Voisard JJ, DelarueA, Lebbé G, Taieb A, Léauté-Labrèze C, Ezzedine K. Safety of propranolol therapy for severe infantile hemangiomas. JAMA 2016; 315(4):413-5. (IF: 35.3, Rang SIGAPS A).

24. Deschasaux M, Souberbielle JC, Latino-Martel P, Sutton A, Charnaux N, Druesne-Pecollo N, Galan P, Hercberg S, Le Clerc S, Kesse-Guyot E, Ezzedine K, Touvier M. Prospective

associations between vitamin D status, vitamin D-related gene polymorphisms and risk of tobacco-related cancers. Am J Clin Nutr 2015 (in press) (IF: 6.770, Rang SIGAPS A).

25. Salzes C, Abadie S, Seneschal J, Whitton M, Meurant JM, Jouary T, Ballanger F, Boralevi F, Taieb A, Taieb C, Ezzedine K. The Vitiligo Impact Patient scale (VIPs): development and validation of a vitiligo burden assessment tool. J Invest Dermatol 2015 (in press) (IF: 7.216, Rang SIGAPS A).

26. Donnenfeld M, Deschaseaux M, Latino-Martel P, Galan P, Hercberg S, Ezzedine K, Touvier

M. Prospective association between dietary folate intake and skin cancer risk: results from the SU.VI.MAX cohort. Am J Clin Nutr 2015; 102: 471-8 (IF: 6.770, Rang SIGAPS A).

27. Ezzedine K, Grimes PE, Meurant JM, Seneschal J, Léauté-Labrèze C, Jouary T, Taieb C,

Taieb A. Living with vitiligo: results from a national survey indicate differences between skin phototypes. Br J Dermatol 2015 (in press) (IF: 4.275, Rang SIGAPS A).

28. Jouary T, Kubica E, Dalle S, Pages C, Duval-Modeste AB, Guillot B, Mansard S, Saiag P, Aubin F, Bedane C, Dalac S, Dompmartin A, Granel-Brocard F, Lok C, Stoebner PE, Lacour JP, Leccia MT, Diallo A, Mateus C*, Ezzedine K *. Sentinel node status and

Immunosuppression: Factors of recurrence in localized Merkel Cell Carcinoma. Acta Derm Venereol 2015 (in press) (IF: 3.025, Rang SIGAPS A). (*Contributeur équivalent)

29. Eleftheriadou V, Thomas K, van Geel N, Hamzavi I, Lim H, Suzuki T, Katayama I, Anbar T, Abdallah M, Benzekri L, Gauthier Y, Harris J, Silva de Castro CC, Pandya A, Goh BK, Lan CC, Oiso N, Al Issa A, Esmat S, Le Poole IC, Lee AI, Parsad D, Taieb A, Picardo A, Ezzedine K. On behalf of the Vitiligo Global Issues Consensus Group (VGICG). Developing core outcomes set for vitiligo clinical trials: International e-Delphi Consensus. Pigment Cell Melanoma Res 2015; 28: 363-9 (IF: 4.619, Rang SIGAPS B).

30. Whitton ME, Pinart M, Batchelor J, Leonardi-Bee J, González U, Jiyad Z, Eleftheriadou V, Ezzedine K. Interventions for vitiligo. Cochrane Database Syst Rev 2015; 2:CD003263

(IF: 6.032, Rang SIGAPS A). 31. Cavalié M, Ezzedine K, Fontas E, Montaudié H, Castela M, Bahadoran P, Taieb A, Lacour

JP, Passeron T. Maintenance therapy of adult vitiligo with 0.1% tacrolimus ointment: a randomized, double blind, placebo-controlled study. J Invest Dermatol 2015; 135: 970-4 (IF: 7.216, Rang SIGAPS A).

32. Touvier M, Deschaseaux M, Monturcy M, Sutton N, Charnaux N, Kesse-Guyot E, Assman

Page 4 / 12

K, Fezeu L, Latino-Martel P, Druesne-Pecollo N, Guinot C, Malvy D, Latreille J, Galan P, Hercberg S, Leclerc S, Souberbielle JC, Ezzedine K. Determinants of 25OHD status in

Caucasian adults: influence of sun exposure, dietary vitamin D intake, socio-demographic, lifestyle, anthropometric and genetic factors. J Invest Dermatol 2015; 135: 378-88 (IF: 7.216, Rang SIGAPS A).

33. Ezzedine K *, Dutkiewicz AD*, Mazereeuw-Hautier J, Lacour JP, Barbarot S, Vabres P,

Miquel J, Balguerie V, Martin L, Boralevi F, Bessou P, Chateil JF, Léauté-Labrèze C. On behalf of the Groupe de Recherche Clinique en Dermatologie Pédiatrique. A prospective study of risk factors for leptomeningeal angiomata in children with upper facial port-wine stain. J Am Acad Dermatol 2015; 72: 473-80 (IF: 4.449, Rang SIGAPS A). (*Contributeur

équivalent) 34. Ezzedine K, Mahé A, van Geel N, Cardot-Leccia N, Gauthier Y, Descamps V, Al Issa A, Ly

F, Chosidow O, Taieb A, Passeron T. Hypochromic vitiligo: delineation of a new entity. Br J Dermatol 2015; 172: 716-21 (IF: 4.275, Rang SIGAPS A).

35. Seneschal J, Boniface K, Ezzedine K, Taieb A. Accelerating bleaching in vitiligo: balancing benefits vs risks. Exp Dermatol 2015; 23: 879-80 (IF: 4.115, Rang SIGAPS A).

36. Descamps V, Mahé E, Maccari F, Begon E, Barthelemy H, Reguiai Z, Bénéton N, Estève E, Chaby G, Ruer-Mulard M, Steiner HG, Thomas-Beaulieu D, Avenel-Audran M, Goujon-Henry C, Sigal ML, Ezzedine K, Beauchet A. Severe androgenetic alopecia as a proxy of metabolic syndrome in male psoriatic patients older than 59 years. Eur J Dermatol 2014; 24: 356-60 (IF: 1.990, Rang SIGAPS C).

37. Dreyfus I, Bourrat E, Maruani A, Bessis D, Chiavérini C, Vabres P, Ezzedine K, Mazereeuw

- Hautier J. Factors associated with impaired quality of life in adult patients suffering from inherited ichthyosis. Acta Derm Venereol 2015; 94: 344-6 (IF: 3.025, Rang SIGAPS A).

38. Touvier M, Deschasaux M, Montourcy M, Sutton A, Charnaux N, Kesse-Guyot E, Fezeu LK, Latino-Martel P, Druesne-Pecollo N, Malvy D, Galan P, Hercberg S, Ezzedine K,

Souberbielle JC. Interpretation of plasma PTH concentrations according to 25OHD status, gender, age, weight status, and calcium intake: importance of the reference values. J Clin Endocrinol Metab 2014; 99: 1196-203.

39. Frascari F, Dreyfus I, Rodriguez L, Gennero L, Ezzedine K, Salles JP, Mazereeuw-Hautier

J. Prevalence and risk factors of vitamin D deficiency in patients with inherited ichthyosis. Orphanet J Rare Dis 2014; 9: 127 (IF: 3.358, Rang SIGAPS B).

40. Ezzedine K *, Gey A*, Diallo A, Prey S, Dreyfus I, Maza I, Mazereeuw-Hautier J, Taieb A, Léauté-Labrèze C. Stay in NICU and infantile hemangioma development. J Eur Acad Dermatol Venereol 2015; 29: 566-73 (IF: 2.826, Rang SIGAPS B). (*Contributeur

équivalent) 41. Taieb A, Boralevi F, Seneschal J, Merhand S, Georgescu V, Taieb C, Ezzedine K. The

atopic dermatitis burden scale–adult: development and validation of a new assessment tool (ABS-A). Acta Derm Venereol 2015; 95: 700-5. (IF: 3.025, Rang SIGAPS A).

42. Ezzedine K, Eleftheriadou V, Whitton M, Nan Geel N. Vitiligo. Lancet 2015; 386: 74-84. (IF:

45.217, Rang SIGAPS A). 43. Hosseini M, Ezzedine K, Taieb A, Rezvani H. Nucleotide excision repair diseases: Oxidative

and energy metabolism as a potential explanation underlying clinical heterogeneity. J Invest Dermatol 2015; 135: 341-51 (IF: 7.216, Rang SIGAPS A).

44. Hu HH, Benfodda M, Dumaz N, Gazal S, Descamps V, Bourillon A, Basset-Seguin N, Riffault A, Ezzedine K, Bagot M, Bensussan A, Saiag P, Grandchamp B, Soufir N. A large

French case-control study emphasizes the role of rare MC1R variants in melanoma risk. Biomed Res Int 2014; 2014:925716. doi: 10.1155/2014/925716. (IF: 1.579, Rang SIGAPS C).

45. Dreyfus I, Chouquet C, Ezzedine K, Henner S, Chiavérini C, Maza A, Pascal S, Rodriguez

L, Vabres P, Martin L, Mallet S, Barbarot S, Dupuis J, Mazereeuw-Hautier J. Prevalence of inherited ichthyosis in France: a study using capture-recapture method. Orphanet J Rare Dis 2014; 9: 1 (IF: 3.358, Rang SIGAPS B).

46. Boralevi F, Diallo A, Miquel J, Guerin-Moreau M, Bessis D, Chiaverini C, Plantin P, Hubiche T, Maruani A, Lassalle M, Boursault L, Ezzedine K. Clinical phenotype of scabies according

to age. Pediatrics 2014; 133: e910-6 (IF: 5.473, Rang SIGAPS A). 47. Eytan O, Morice-Picard F, Sarig O, Ezzedine K, Isakov O, Li Q, Ishida-Yamamoto A,

Shomron N, Goldsmith T, Fuchs-Telem D, Adir N, Uitto J, Orlow SJ, Taieb A, Sprecher E. Cole Disease Results from Mutations in ENPP1. Am J Hum Genet 2013; 93: 752-7 (IF: 10.931, Rang SIGAPS A).

48. Ezzedine K, le Thuaut A, Jouary T, Ballanger F, Taieb A, Bastuji-Garin S. Latent Class

Analysis of a series of 717 patients with vitiligo allows the identification of two clinical subtypes. Pigment Cell Melanoma res 2014; 27: 134-9 (IF: 4.619, Rang SIGAPS B).

49. Marie J, Kovacs D, Pain C, Jouary T, Cota C, Vergier B, Picardo M, Taieb A, Cario-André M, Ezzedine K *. NLRP1 inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol 2014; 170: 816-23 (IF: 4.275, Rang SIGAPS A). (*Contributeur équivalent)

50. Latreille J, Kesse-Guyot E, Malvy D, Andreeva V, Galan P, Tschachler E, Hercberg S, Guinot C, Ezzedine K. Association between dietary intake of n-3 polyunsaturated fatty acids and severity of skin photoaging in a middle-aged Caucasian population. J Dermatol Sci 2013; 72: 233-9 (IF: 3.419, Rang SIGAPS B).

51. Ahogo C, Ezzedine K, Prey S, Colona V, Diallo A, Boralevi F, Taieb A, Labrèze C. Factors

associated with the relapse of infantile hemangiomas in children treated with oral propranolol. Br J Dermatol 2013; 169: 1252-6 (IF: 4.275, Rang SIGAPS A).

52. Hadj-Rabia S, Oriot D, Soufir N, Dufresne H, Bourrat E, Mallet S, Poulhalon N, Ezzedine K,

Grandchamp B, Taïeb A, Catteau B, Sarasin A, Bodemer C. Unexpected extradermatological findings in 31 patients with xeroderma pigmentosum type C. Br J Dermatol 2013; 168: 1109-13 (IF: 4.275, Rang SIGAPS A).

53. Jdid R, Ezzedine K, Latreille J, Galan P, Hercberg S, Malvy D, Tschachler E, Guinot C. MC1R major variants are a risk factor of sleep lines in Caucasian women. J Eur Acad Dermatol Venereol 2014; 28: 805-9. (IF: 2.826, Rang SIGAPS B).

54. Morice-Picard F, Ezzedine K, Delrue MA, Lacombe D, Taieb A, Boralevi F. Cutaneous

manifestations in Costello and Cardiofaciocutaneous syndrome: report of 18 cases and literature review. Pediatric Dermatol 2013; 30: 665-73 (IF: 1.015, Rang SIGAPS D).

55. Diallo A, Boniface K, Jouary T, Seneschal J, Morice-Picard F, Prey S, Cario-André M, Mazereeuw-Hautier J, Taieb A, Ezzedine K. Development and validation of the K-VSCOR for scoring Koebner’s phenomenon in Vitiligo/non-segmental vitiligo. Pigment Cell Melanoma res 2013; 26: 402-7 (IF: 4.619, Rang SIGAPS B).

56. Benzekri L, Ezzedine K, Gauthier Y. Vitiligo potential repigmentation index (PRI): A simple

clinical score that might predict vitiligo lesions ability to repigment under therapy. Br J Dermatol 2013; 168: 1143-6 (IF: 4.275, Rang SIGAPS A).

57. Gey A, Diallo A, Seneschal J, Léauté-Labrèze C, Boralevi F, Jouary T, Taieb A, Ezzedine K.

Auto-immune thyroid stigma in vitiligo: multivariate analysis indicates intricated pathomechanisms. Br J Dermatol 2013; 168: 756-61 (IF: 4.275, Rang SIGAPS A).

58. Léauté-Labrèze C, Dumas de la Roque E, Nacka F, Abouelfath A, Grenier N, Rebola M, Ezzedine K, Moore N. Double blind randomized trial evaluating the safety and efficacy of oral propranolol in the early phase treatment of infantile haemangioma. Br J Dermatol 2013 169: 181-3 (IF: 4.275, Rang SIGAPS A).

59. Mazereeuw-Hautier J, Dreyfus I, Barbarot S, Maza A, Galera I, Bourrat E, Chiaverini C, Ezzedine K, Le Rhun A, Taieb C. IQoL: a new icthyosis-specific measure of quality of life. J Am Acad Dermatol 2013; 69: 82-7 (IF: 4.449, Rang SIGAPS A).

60. Le Clerc S, Taing L, Ezzedine K, Latreille J, Labib T, Coulonges C, Bernard A, Melak S,

Carpentier W, Malvy D, Jdid R, Galan P, Hercberg S, Morizot F, Guinot C, Tschachler E, Zagury JF. A Genome-Wide Association Study in Caucasian women points out for a role of the STXBP5L gene in facial photoageing. J Invest Dermatol 2013; 133: 929-35 (IF: 7.216, Rang SIGAPS A).

61. Prey S, Ezzedine K, Mazereeuw-Hautier J, Eschard C, Barbarot S, Boralevi F, Taieb A,

Léauté-Labrèze C, and on behalf of the Groupe de Recherche Clinique en Dermatologie Pédiatrique. IFAG and childhood rosacea: a possible link? Pediatric Dermatol 2013; 30: 429-32 (IF: 1.015, Rang SIGAPS D).

62. Prey S, Ezzedine K, Doussau A, Grandoulier AS, Barcat D, Chatelus E, Diot E, Durant C,

Hachulla E, de Korwin-Krokowski, Kostrezwa E, Quemeneur T, Paul C, Schaeverbeke T, Seneschal J, Solanilla A, Sparsa A, Bouchet S, Lepreux S, Mahon FX, Chêne G, Taieb A. Imatinib mesylate in systemic sclerosis associated- diffuse skin fibrosis: a phase II randomized controlled double-blinded versus placebo multicentric trial. Br J Dermatol 2012; 167: 1138-44 (IF: 4.275, Rang SIGAPS A).

63. Ezzedine K, Mauger E, Latreille E, Jdid R, Malvy D, Gruber F, Galan P, Hercberg S,

Tschachler E, Guinot C. Freckles and solar lentigines have different risk factors in Caucasian women. J Eur Acad Dermatol Venereol 2013; 27: e345-e356 (IF: 2.826, Rang SIGAPS B).

64. Latreille J, Kesse-Guyot E, Malvy D, Andreeva V, Galan P, Tschachler E, Hercberg S, Guinot C, Ezzedine K. Dietary monounsaturated fatty acids intake and risk of skin photoaging. Plos One 2012; 7: e44490 (IF: 3.234, Rang SIGAPS B).

65. Seneschal J, Kubica E, Boursault L, Stokkermans J, Labrèze C, Milpied B, Ezzedine K,

Taieb A. Exogenous inflammatory acne due to combined application of cosmetic and facial rubbing. Dermatology 2012; 224: 221-3 (IF: 1.569, Rang SIGAPS C).

66. Droitcourt C, Milpied B, Ezzedine K, Hubiche T, Belin E, Akpadjan F, Taieb A, Seneschal J.

Interest of high dose pulse corticosteroid therapy combined with methotrexate for severe alopecia areata: a retrospective case series. Dermatology 2012; 224: 369-73 (IF: 1.569, Rang SIGAPS C).

67. Ezzedine K, Droitcourt C, Ged C, Diallo A, Hubiche T, de Verneuil H, Boralevi F, Taieb A.

Usefulness of a global clinical ichthyosis vulgaris scoring system for predicting common FLG null mutations in an adult Caucasian population. Br J Dermatol 2012; 167: 1165-9 (IF: 4.275, Rang SIGAPS A).

68. Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CCE, Goh BK, Anbar T, Silva

de Castro C, Lee AY, Parsad D, van Geel N, Le Poole IC, Oiso N, Benzekri1 L, Spritz R, Y Gauthier Y, Hann SK, Picardo M, A Taieb. On behalf of the Vitiligo Global Issue Consensus Conference panelists*. Revised classification/nomenclature of vitiligo and related issues: The Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma res 2012; 25: E1-13 (IF: 4.619, Rang SIGAPS B).

69. AlGhamdi KM, Khurrum H, Taieb A, Ezzedine K. Treatment of generalized vitiligo with anti TNF-α agents. J Drugs Dermatol 2012; 11: 534-9 (IF: 1.446, Rang SIGAPS D).

70. Ezzedine K, Diallo A, Léauté-Labrèze C, Seneschal J, Boniface K, Cario-André M, Prey S,

Page 6 / 12

Ballanger F, Boralevi F, Jouary T, Mossalayi D, Taieb A. Pre vs post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo. Br J Dermatol 2012; 167: 490-5 (IF: 4.275, Rang SIGAPS A).

71. Ezzedine K, Diallo A, Léauté-Labrèze C, Séneschal J, Prey S, Ballanger F, Alghamdi K,

Cario-André M, Jouary T, Gauthier Y, Taieb A. Halo nevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo. Br J Dermatol

2012; 166: 539-44 (IF: 4.275, Rang SIGAPS A). 72. Ricard AS, Pain C, Daubos A, Ezzedine K, Lamrissi-Garcia I, Bibeyran A, Guyonnet-

Duperat V, Taieb A, Cario-André M. Study of CCN3 (Nov) and DDR1 in normal melanocytes and vitiligo skin. Exp dermatol 2012; 21: 411-6 (IF: 3.762, Rang SIGAPS A).

73. AlGhamdi KM, Kumar A, Taieb A, Ezzedine K. Assessment Methods for the Evaluation of Vitiligo. J Eur Acad Dermatol Venereol 2012; 26: 1463-71(IF: 2.826, Rang SIGAPS B).

74. Jin Y, Birlea SA, Fain PR, Ferrara TM, Ben S, Riccardi SL, Cole JB, Gowan K, Holland PJ, Bennett DC, Luiten RM, Wolkerstorfer A, van der Veen JPW, Hartmann A, Eichner S, Schuler G, van Geel N, Lambert J, Kemp EH, Gawkrodger DJ, Weetman AP, Taïeb A, Jouary T, Ezzedine K, Wallace MR, McCormack WT, Picardo M, Leone G, Overbeck A,

Silverberg NB, Spritz RA. Genome-wide association study identifies melanocyte-specific and immunoregulatory susceptibility loci for generalized vitiligo. Nat genet 2012; 44: 676-80

(IF: 29.352, Rang SIGAPS A). 75. Mazereeuw-Hautier J, Dreyfus I, Barbarot S, Serrentino L, Bourdon-Lannoy E, Ezzedine K,

Maza A, Aujoulat I, Le Rhun A. Factors influencing quality of life of inherited adult ichthyosis: a qualitative study using focus groups. Br J Dermatol 2012; 166: 646-8 (IF: 4.275, Rang SIGAPS A).

76. Ezzedine K, Diallo A, Léauté-Labrèze C, Séneschal J, Mossalayi D, AlGhamdi K, Prey S,

Bouchtnei S, Cario-André M, Boralevi F, Jouary T, Taieb A. Halo nevi association in nonsegmental vitiligo influences age of onset and depigmentation pattern. Arch Dermatol 2012; 148: 497-502 (IF: 4.789, Rang SIGAPS A).

77. Hu H-H, Guedj M, Descamps V, Jouary T, Bourillon A, Ezzedine K, Taieb A, Bagot M,

Bensussan A, Saiag P, Grandchamp B, Basset-Seguin N, Soufir N. Assessment of Tyrosinase variants and skin cancer risk in a large cohort of French subjects. J Dermatol Sci 2011; 63: 127-33 (IF: 3.419, Rang SIGAPS B).

78. van Geel N, Reinhart S, Taieb A, Picardo M, Böhm M, Gawkrodger DJ, Schallreuter K, Bennett DC, van der Veen W, Moretti S, Westerhof W, Ezzedine K, Gauthier Y, and on

behalf of the other VETF members. Koebner phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res 2011; 24: 564-73 (IF: 4.619, Rang SIGAPS B).

79. Ezzedine K, Diallo A, Léauté-Labrèze C, Mossalayi D, Gauthier Y, Bouchtnei S, Cariot-

André M, Seneschal J, Boralevi F, Jouary T, Taieb A. Multivariate analysis of factors associated with early onset segmental and non-segmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol 2011; 165: 44-9 (IF: 4.275, Rang

SIGAPS A). 80. Elfakir A, Ezzedine K, Latreille J, Ambroisine L, Jdid R, Galan P, Hercberg S, Gruber F,

Malvy D, Tschachler E, Guinot C. Polymorphismes du MC1R et photovieillissement du visage. Ann Dermatol Venereol 2011; 138 : 385-9 (IF: 0.919, Rang SIGAPS E).

81. Droitcourt C, Touboul D, Ged C, Ezzedine K, Cario-André M, de Verneuil H, Colin J, Taieb

A. A prospective study of filaggrin null mutations in Keratoconus patients with or without atopic disorders. Dermatology 2011; 222:336-341 (IF: 1.569, Rang SIGAPS C).

82. Belin E, Ezzedine K, Lalanne N, Beylot-Barry M, Stanislas S, Taieb A, Vergier B, Jouary T.

Factors in the surgical management of primary eccrine porocarcinoma: prognostic histological factors can guide the surgical procedure. Br J Dermatol 2011; 165: 985-9 (IF: 4.275, Rang SIGAPS A).

83. Ezzedine K, Gauthier Y, Léauté-Labrèze C, Marquez S, Bouchtnei S, Jouary T, Taieb A.

Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients. J Am Acad Dermatol 2011: 65: 965-71 (IF: 4.449, Rang SIGAPS A).

84. Birlea SA, Jin Y, Bennet DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van

Geel N, Lambert J, Overbeck A, Fain PR, Spritz RA. Comprehensive analysis of vitiligo candidate genes supports primary association of XBP1, and FOXP3, and TSLP. J Invest Dermatol 2011; 131: 271-381 (IF: 7.216, Rang SIGAPS A).

85. Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, Van Geel N, Lambert J, Overbeck A, Spritz RA. Genome-Wide

Analysis Identifies a Quantitative Trait Locus in the MHC Class II Region Associated with Generalized Vitiligo Age of Onset. J Invest Dermatol 2011; 131: 1308-12 (IF: 7.216, Rang SIGAPS A).

86. Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJD, Hutton SM, Amadi-Myers A, Bennett DC, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, Geel N,

Lambert J, Overbeck A, Spritz RA. Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med 2010; 362: 1686-97 (IF: 55.873, Rang SIGAPS A).

87. Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Mailloux CM, Sufit AJD, Hutton SM, Amadi-Myers A, Bennett DC, Wallace MR, McCormack WT, Kemp EH,

Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, Geel N,

Lambert J, Overbeck A, Spritz RA. Common variants of FOXP1 are associated with generalized vitiligo. Nat Genet 2010; 42: 576-8 (IF: 29.352, Rang SIGAPS A).

88. Ezzedine K, Latreille J, Kesse-Guyot E, Galan P, Hercberg S, Guinot C, Malvy D. Incidence

of skin cancers during five-year follow-up after stopping antioxidant vitamins and mineral supplementation. Eur J Cancer 2010; 46: 3316-22 (IF: 5.417, Rang SIGAPS B).

89. Sissoko D, Ezzedine K, Giry C, Moendandzé A, Lernout T, D'Ortenzio E, Pettinelli F, Malvy D. Seroepidemiology of Dengue virus in Mayotte, Indian Ocean, 2006. PLoS One 2010; 5: e14141 (IF: 3.234, Rang SIGAPS B).

90. Larrieu S, Pouderoux N, Pistone T, Receveur MC, Sissoko D, Filleul L, Ezzedine K, Malvy

D. Factors associated with persistence of arthralgia among chikungunya virus-infected travellers: report of 42 French cases. J Clin Virol 2010; 41: 85-8 (IF: 3.016, Rang SIGAPS A).

91. Ezzedine K, Pistone T, Gaudin AF, Hercberg S, Nachbaur G, Malvy D. Malaria prevention

behaviour and risk awareness in French adult travelers. Travel Med Infect Dis 2010; 8: 13-21 (IF: 1.538, Rang SIGAPS C).

92. Vanhecke C, Malvy D, Guevart E, Laloge V, Ezzedine K. Paederus dermatitis : à propos de

74 cas groupés au Centre Médical Français de Conakry, Guinée, Octobre- Décembre 2008. Ann Dermatol Venereol 2010; 137: 189-93 (IF: 0.919, Rang SIGAPS E).

93. Sissoko D, Ezzedine K, Moendandzé A, Giry C, Renault P, Malvy D. Field evaluation of

clinical features during chikungunya outbreak in Mayotte, 2005-2006: implications for community-based active surveillance purposes. Trop Med Int Health 2010; 15: 600-7 (IF: 2.329, Rang SIGAPS B).

94. Elfakir A, Ezzedine K, Latreille J, Ambroisine L, Jdid R, Galan P, Hercberg S, Gruber F,

Malvy D, Tschachler E, Guinot C. Functional MC1R gene variants are associated with an increased risk of severe photoaging of facial skin. J Invest Dermatol 2010; 130: 1107-15 (IF: 7.216, Rang SIGAPS A).

95. Jouary T, Legros C, Lalanne N, Versapuech J, Ezzedine K, Vergier B, Delaunay M, Velly JF,

Taieb A. Neoadjuvant chemotherapy: a new selection criterion for candidate surgery of low tumor burden metastases from malignant melanoma. Br J Dermatol 2010; 163: 183-7 (IF: 4.275, Rang SIGAPS A).

96. Vanhecke C, Guevart E, Ezzedine K, Receveur MC, Jamonneau V, Bucheton B, Camara

M, Vincendeau P, Malvy D. La trypanosomose humaine africaine en faciès épidémiologique de mangrove. Présentation, déterminants et prise en charge dans le contexte de la Guinée (2005-2007). Pathol Biol 2010; 58: 210-6 (IF: 1.200, Rang SIGAPS E).

97. Robin S, Ramful D, Zettor J, Benhamou L, Jaffar-Bandjee MC, Rivière JP, Marichy J, Ezzedine K, Alessandri L. Severe bullous skin lesions associated with chikungunya virus infection in small infants. Eur J Pediatr 2010; 169: 67-72 (IF: 1.890, Rang SIGAPS C).

98. Vereecken P, Awada A, Suciu S, Castro G, Morandini R, Litynska A, Lienard D, Ezzedine K,

Ghanem G, Heenen M.Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients. Melanoma Res 2009; 19: 316-20 (IF: 2.282, Rang SIGAPS C).

99. Sans V, Dumas de la Roque E, Berge J, Grenier N, Boralevi F, Mazereeuw-Hautier J, Lipsker D, Dupuis E, Ezzedine K, Vergnes P, Taïeb A, Léauté-Labrèze C. Propanolol for severe infantile hemangiomas : a follow-up report. Pediatrics 2009; 124: e423-e431 (IF: 5.473, Rang SIGAPS A).

100. Kostopoulou P, Jouary T, Quintard B, Ezzedine K, Marques S, Boutchnei S, Taieb A.

Objective vs subjective factors in the psychological impact of vitiligo : the experience of a French referral centre. Br J Dermatol 2009; 161: 128-33 (IF: 4.275, Rang SIGAPS A).

101. Latreille J, Ezzedine K, ElFakir A, Ambroisine L, Gardinier S, Galan P, Hercberg S, Gruber

F, Rees J, Tschachler E, Guinot C. MC1R gene polymorphism affects skin color measured by reflectance in a population of French adult women. Photochem Photobiol 2009; 85: 1451-8 (IF: 2.266, Rang SIGAPS D).

102. Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M, Pierre V. Post-epidemic

chikungunya disease in Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis 2009; 3: e389 (IF: 4.446, Rang SIGAPS A).

103. Valet F, Ezzedine K, Malvy D, Mary JY, Guinot C. Reliability assessment of four severity scales depicting skin aging features. Br J Dermatol 2009; 161: 153-8 (IF: 4.275, Rang SIGAPS A).

104. Rambert J, Mamani-Matsuda M, Moynet D, Bubus P, Delplat V, Kauss T, Dehais J, Schaeverbeke T, Ezzedine K, Malvy D, Vincendeau P, Mossalayi D. Molecular blocking of CD23 supports its role in the pathogenesis of arthritis. PLoS One 2009; 4: e4834 (IF: 3.234, Rang SIGAPS B).

105. Ezzedine K, Pistone T, Boisvert M, Receveur MC, Schuffenecker I, Zeller H, Lafon ME,

Fleury H, Malvy D. Cluster of chikungunya virus infection in travellers returning from Senegal, 2006. J Travel Med 2009; 4: 289-91 (IF: 1.579, Rang SIGAPS C).

106. Sissoko D, Moendandze A, Malvy D, Giry C, Ezzedine K, Solet J-L, Pierre V.

Seroprevalence and risk factors of chikungunya virus infection in Mayotte, Indian Ocean, 2005-2006: a population-based survey. PLoS One; 2008; 3: e3066 (IF: 3.234, Rang SIGAPS B).

Page 8 / 12

107. de Carsalade GY, Receveur MC, Ezzedine K, Saget J, Achirafi A, Bobin P, Malvy D.

Dépistage actif intra-domiciliaire différé de la lèpre: expérience de l’équipe de dépistage sur l'île de Mayotte. Bull Soc Path Exot 2008; 100: 32-5.

108. Ezzedine K, Amiel A, Vereecken P, Simonart T, Schietse B, Seymons K, Ndiaye BS, Van de

Leemput C, Lambert J, Heenen M. BlackSkin Dermatology Online, from the project to the website: a needed collaboration between North and South. J Eur Acad Dermatol Venereol 2008; 22: 1193-9 (IF: 2.826, Rang SIGAPS B).

109. Pistone T, Schwarzinger M, Chauvin P, Ezzedine K, Receveur MC, Djossou F, Siriwirdana

M, Larouzé B, Malvy D. Reimbursement of malaria chemoprophylaxis for travellers from Europe to Sub-Saharian Africa: cost-effectiveness analysis from the perspective of the French Healthcare System. Health Policy 2008; 88: 186-99 (IF: 1.907, Rang SIGAPS C).

110. Ezzedine K, Malvy D, Receveur MC, Pistone T, Crevon L, Lemardeley P, Josse R. Cluster

of eosinophilic meningitis attributable to A. cantonensis infection in French policemen troop returning from the Pacific Islands. Travel Med Infect Dis 2008; 6: 301- 4 (IF: 1.538, Rang

SIGAPS C). 111. Ezzedine K, Malvy D, Mauger E, Galan P, Hercberg S, Guinot C. Artificial and natural

ultraviolet radiation exposure: beliefs and behaviour of 7,200 French adults. J Eur Acad Dermatol Venereol 2008; 22: 186-94 (IF: 2.826, Rang SIGAPS B).

112. Valet F, Mary JY, Ezzedine K, Guinot C. Quality assessment of ordinal scale reproducibility: log-linear models provided useful information on scale structure. J Clin Epidemiol 2008; 61: 983-90 (IF: 3.417, Rang SIGAPS A).

113. Bley D, Vernazza-Licht N, Pistone T, Reviriego J, Djossou F, Receveur MC, Ezzedine K,

Malvy D.Understanding and awareness of malaria among 103 French individuals traveling to endemic areas, having consulted the Bordeaux university hospital travel clinic, France. Med Mal Infect 2007; 37 : 678-83 (IF: 1.237, Rang SIGAPS E).

114. Hercberg S, Ezzedine K, Guinot C, Preziosi P, Galan P, Bertrais S, Estaquio C, Briançon S,

Favier A, Malvy D. Antioxidant supplementation increases the risk of skin cancers in women but not in men. J Nutr 2007; 137: 2098-105 (IF: 3.875, Rang SIGAPS B).

115. Ambroisine L, Ezzedine K, Elfakir A, Gardinier S, Latreille J, Mauger E, Tenenhaus M,

Guinot C. Relationships between visual and tactile features and skin biophysical parameters in human facial skin. Skin Res Technol 2007; 13: 176-83 (IF: 1.536, Rang SIGAPS D).

116. Ezzedine K, Guinot C, Mauger E, Pistone T, Rafii N, Receveur MC, Galan P, Hercberg S,

Malvy D. Expatriates in high UV index and tropical countries: sun-exposure and protection behaviour in 9416 French adults. J Travel Med 2007; 14: 85-91 (IF: 1.579, Rang SIGAPS C).

117. Ezzedine K, Guinot C, Mauger E, Pistone T, Receveur MC, Galan P, Hercberg S, Malvy D.

Travellers to high UV index countries: sun-exposure behaviour in 7822 French adults. Travel Med Infect Dis 2007; 5: 176-82 (IF: 1.538, Rang SIGAPS C).

118. Pistone T, Guibert P, Gay F, Malvy D, Ezzedine K, Receveur MC, Siriwardana M, Larouzé

B, Bouchaud O. Malaria risk perception, knowledge and prophylaxis practices among travellers of African ethnicity living in Paris and visiting their country of origin in sub-Saharan Africa. Trans R Soc Trop Med Hyg 2007; 101: 990-5 (IF: 1.839, Rang SIGAPS B).

119. Malvy D, Ezzedine K, Lançon F, Halioua B, Rezvani A, Bertrais S, Chanzy B, Daniloski M,

Malkin JE, Morand P, De Labareyre C, Hercberg S, El Hasnaoui A. Epidemiology of orofacial herpes simplex virus infections in a general population in France: results of the Herpimax study. J Eur Acad Dermatol Venereol 2007; 21: 1398-403 (IF: 2.826, Rang SIGAPS B).

120. Ezzedine K, Darie H, Le Bras M, Malvy D. Skin features accompanying imported human

African trypanosomiasis: hemolymphatic Trypanosoma gambiense infection among two French expatriates with dermatologic manifestations. J Travel Med 2007; 14: 192-6 (IF: 1.579, Rang SIGAPS C).

121. Guinot C, Malvy D, Mauger E, Ezzedine K Ezzedine K, Latreille J, Tenenhaus M, Galan P,

Hercberg S, Tschachler E. Self-reported skin sensitivity in a general adult population in France: data of the SU.VI.MAX cohort. J Eur Acad Dermatol Venereol 2006; 20: 380-90 40 (IF: 2.826, Rang SIGAPS D).

122. Guinot C, Ezzedine K, Mauger E, Ambroisine L, Latreille J, Preziosi P, Galan P, Chapuy

MC, Arnaud S, Meunier JP, Tschachler E, Hercberg S, Malvy D. Phototype, vitamin D status and bone mineral density in women at risk for osteoporosis. Rev Med Int 2006; 27: 369-74 (IF: 1.074, Rang SIGAPS B).

123. Malvy D, Halioua B, Lançon F, Rezvani A, Bertrais S, Chanzy B, Daniloski M, Ezzedine K,

Malkin JE, Morand P, De Labareyre C, Hercberg S, El Hasnaoui A. Epidemiology of genital herpes simplex virus infections in a community-based sample in France: results of the herpimax study. Sex Transm Dis 2005; 32: 499-505 (IF: 2.842, Rang SIGAPS C).

124. Guinot C, Malvy D, Latreille J, Ezzedine K, Latreille J, Galan P, Tenenhaus M, Ambroisine L,

Lê S, Hercberg S, Tschachler E. Sun reactive skin type in a French general adult population. Photochem Photobiol 2005; 81: 934-40 (IF: 2.266, Rang SIGAPS D).

REFERENCED PUBLICATIONS

(CASE REPORTS AND LETTERS TO THE EDITOR)

1. Amazan E, Ezzedine K, Mossalayi D, Taieb A, Boniface K, Seneschal J. Expression of interleukin-1 alpha in amicrobial pustulosis of the skin folds with complete response to Anakinra. J Am Acad Dermatol 2014; 71: e53-6.4 (IF: 4.449, Rang SIGAPS A).

2. Dousset L, Seneschal J, Boniface K, Charreau S, Ezzedine K, Milpied B, Mossalayi MD,

McGrath JA, Lecron JC, Taieb A. A Th2 Cytokine Interleukin 31 Signature in a Case of Sporadic Lichen Amyloidosis. Acta Derm Venereol 2015; 95: 223-4 (IF: 3.025, Rang SIGAPS A).

3. Seneschal J, Guillet S, Ezzedine K, Taieb A, Milpied B. Alternative procedure to allow

continuation of Dapsone therapy despite serious adverse reaction in a case of Dapsone Sensitive Erythema Elevatum Diutinum. Dermatology 2012; 224: 115-9 (IF: 1.569, Rang SIGAPS C).

4. Cante V, Pham-Ledard A, Imbert E, Ezzedine K, Léauté-Labrèze C. First report of topical timolol

treatment in primarily ulcerated perineal hemangioma. Arch Dis Child Fetal Neonatal Ed 2012; 97: F155-6 (IF: 3.120, Rang SIGAPS A).

5. Ezzedine K, Amazan E, Seneschal J, Cario-André M, Léauté-Labrèze C, Vergier B, Boralevi F, Taieb A. Follicular vitiligo: a new form of vitiligo. Pigment Cell Melanoma Res 2012; 25: 527-9

(IF: 4.619, Rang SIGAPS B). 6. Receveur M, Ezzedine K, Pistone T, Malvy D. Chikungunya infection in a French traveller

returning from the Maldives, October, 2009. Euro Surveill 2010; 15: 19494 (IF: 5.722, Rang SIGAPS A).

7. Pradines B, Pistone T, Ezzedine K, Briolant S, Bertaux L, Receveur MC, Parzy D, Millet P,

Rogier C, Malvy D. Quinine-resistant malaria in traveler returning Senegal, 2007. Emerg Infect Dis 2010; 16: 546-8 (IF: 6.751, Rang SIGAPS A).

8. Houdon L, Flodrops H, Rocaboy M, Bintner M, Fériot JP, Tournebize P, Renouil M, Ezzedine K, Malvy D. Two patients with acute imported neuroschistosomiasis due to Schistosoma mansoni. J Travel Med 2010; 17: 274-7 (IF: 1.579, Rang SIGAPS C).

9. Pham-Ledard A, Ezzedine K, Couprie B, Begueret H, Boralevi F, Taieb A. Papillomatose

confluente et reticulée de Gougerot et Carteaud faciale ou “hyperkeratotic head and neck Malassezia dermatosis”. Ann Dermatol Venereol 2010; 137: 451-4 (IF: 0.919, Rang SIGAPS

E). 10. Ezzedine K, Malvy D, Beylot C, Longy-Boursier M. Autochthonous leprosy in metropolitan

France presenting with a diffuse infiltration of the face and febrile illness. Int J Dermatol 2009; 48: 69-72 (IF: 1.312, Rang SIGAPS D).

11. Ezzedine K, Malvy D, Mamani-Matsuda M, Autran B, Tolou H, Receveur MC, Pistone T, D,

Mossalayi D. Destructive arthritis in a patient with chikungunya virus infection with persistent specific IgM antibodies. BMC Infect Dis 2009; 9: 200 (IF: 2.613, Rang SIGAPS C).

12. Pistone T, Ezzedine K, Accocebery I, Receveur MC, Juguet F, Malvy D. Ectopic cutaneous

schistosomiasis – Perigenital infiltrative granulomata in a 34-year-old pregnant woman. Travel Med Infect Dis 2008; 6: 155-7 (IF: 1.538, Rang SIGAPS C).

13. Ezzedine K, Cazanave C, Pistone T, Receveur MC, Neau D, Ragnaud JM, Malvy D. Dual

infection by chikungunya virus and other imported infectious agent in a traveller returning from India. Travel Med Infect Dis 2008; 6: 152-4 (IF: 1.538, Rang SIGAPS C).

14. Ezzedine K, Simonart T, Candaele M, Malvy D, Heenen M. Concomitant Xeroderma

pigmentosum and disseminated small plaque psoriasis: first case of an antinomic association. Cases J 2008; 1: 74.

15. Ezzedine K, Pistone T, Schuffenecker I, Receveur M-C, Malvy D. An imported case of

chikungunya fever from Madagascar: use of the sentinel traveller for detecting emerging arboviral infections in tropical and European countries. Travel Med Infect Dis 2008; 7: 52-4 (IF: 1.538, Rang SIGAPS C).

16. Ezzedine K, Malvy D, Steels E, De Dobbeeler G, Struelens M, Jacobs F, Heenen M. Imported melioidosis with an isolated cutaneous presentation in a 90-year-old traveller. Bull Soc Path Exot 2007; 100: 22-5.

17. Ezzedine K, Accoceberry I, Malvy D. Oral histoplasmosis following radiation therapy for laryngeal

squamous cell carcinoma. J Am Acad Dermatol 2007; 56: 871-3 (IF: 4.449, Rang SIGAPS A). 18. Ezzedine K, Cressend T, Pistone T, Receveur MC, Diéval C, Malvy D. Haemoglobinuria in a 38-

year-old French expatriate man living in Cameroon following artemisinin-based antimalarial treatment. Travel Med Infect Dis 2007; 5: 256-8 (IF: 1.538, Rang SIGAPS C).

19. Ezzedine K, Malvy D, Dhaussy I, Steels E, De Dobbeleer G, Heenen M. Onchocerciasis-

associated limb swelling in a traveller returning from Cameroon. J Travel Med 2006; 13: 50-3 (IF: 1.579, Rang SIGAPS C).

20. Malvy D, Ezzedine K, Pistone T, Receveur MC, Longy-Boursier M. Extensive cutaneous larva

migrans with folliculitis mimicking pseudometameric herpes zoster presentation in a traveller returning from Thailand. J Travel Med 2006; 13: 244-7 (IF: 1.579, Rang SIGAPS C).

21. Malvy D, Ezzedine K, Receveur MC, Pistone T, Mercié P, Longy-Boursier M. Extra-pulmonary

paragonimiasis with unusual arthritis and cutaneous features among a tourist returning from Gabon. Travel Med Infect Dis 2006; 6: 340-2 (IF: 1.538, Rang SIGAPS C).

22. Duvignaud A, Receveur MC, Ezzedine K, Pistone T, Malvy D. Visceral leishmaniasis due to Leishmania infantum in a kidney transplant recipient living in France. Travel Med Infect Dis 2015; 13: 115-6 (IF: 1.538, Rang SIGAPS C).

Page 10 / 12

23. Jouary T, Guillet S, Droitcourt C, Dutriaux C, Ezzedine K, Goussot JF, Taieb A. Lichen sclerosus mimicking halo-nevus comedonicus. J Eur Acad Dermatol Venereol 2015 (in press) (IF: 2.826,

Rang SIGAPS B). 24. Malvy D, Khatibih S, Rivière B, Prudhomme L, Ezzedine K. Challenging issues and pitfalls for

diagnosis of Human African trypanosomiasis in a Gabonese visitor, France. Travel Med Infect Dis 2014; 12: 778-80 (IF: 1.538, Rang SIGAPS C).

25. Mahé A, Ezzedine K. Letter to the Editor concerning the article "Geographical ancestry is a key determinant of epidermal morphology and dermal composition". Br J Dermatol 2014; 171: 1598-9 (IF: 4.275, Rang SIGAPS A).

26. Gey A, Milpied B, Dutriaux C, Mateus C, Robert C, Perro G, Taieb A, Ezzedine K, Jouary T.

Severe cutaneous adverse reaction associated with vemurafenib: DRESS, AGEP or overlap reaction? J Eur Acad Dermatol Venereol 2014 (in press) (IF: 2.826, Rang SIGAPS B).

27. Bertolotti A, Conte H, Louis F, Dutriaux C, Ezzedine K Ezzedine K, Mélard P, Vergier B, Taieb A,

Jouary T. Merkel Cell Carcinoma: Complete Clinical Remission Associated With Disease ProgressionMetastatic Melanoma with Leukaemia-like Evolution. JAMA Dermatol 2013; 149: 501-502 (IF: 4.426, Rang SIGAPS A).

28. Taieb A, Ezzedine K. Vitiligo: the white armor? Pigment Cell Melanoma res 2013; 26: 286-7 (IF:

4.619, Rang SIGAPS B). 29. Bertolotti A, Conte H, Amazan E, Dutriaux C, Ezzedine K, Parrens M, Vergier B, Taieb A, Jouary

T. Metastatic Melanoma with Leukaemia-like Evolution. Acta Derm Venereol 2013; 93: 729-30 (IF: 3.025, Rang SIGAPS A).

30. Ezzedine K, Pistone T. Multiple pruritic papules of the buttocks. CMAJ 2013; 185: E213 (IF:

5.959, Rang SIGAPS A). 31. Ezzedine K, Belin E, Guillet S, D’Almeida M, Droitcourt C, Accocebery I, Milpied B, Jouary T,

Malvy D, Taieb A. Cutaneous hyphomycosis due to P. Lilacinus. Acta Derm Venereol 2012; 92: 156-7 (IF: 3.025, Rang SIGAPS A).

32. Ezzedine K, Simonart T, Malvy D, Bourgoin C, Noel JC. Cutaneous verrucous carcinoma arising

in lupus vulgaris. J Dermatol 2012; 39: 505-7 (IF: 2.252, Rang SIGAPS C). 33. Ezzedine K, Milpied B, Ohayon-Courtès C, Genillier-Foin N, Peyromat M, Taieb A, Léauté-

Labrèze C. Are post-vaccinal persistent itching nodules related to the use of local anaesthetic patches? A hypothesis to confirm. Contact Dermatitis 2012; 66: 343-4 (IF: 3.747, Rang SIGAPS

B). 34. Prevost P, Bédry R, Lacoste D, Ezzedine K, Haramburu F, Milpied B. Hypersensitivity syndrome

with olanzapine confirmed by patch tests. Eur J Dermatol 2012; 26: 126-7 (IF: 1.990, Rang SIGAPS C).

35. Prey S, Haberstroh G, Vergier B, Taieb A, Wassef M, Ezzedine K, Léauté-Labrèze C. Successful

treatment of intrvascular papillarry endothelial hyperplasia (IPEH) by the beta-adrenergic antagonist nevibolol. Br J Dermatol 2012; 166: 1147-9 (IF: 4.275, Rang SIGAPS A).

36. Gauzere BA, Malvy D, Filleul L, Ramful D, Jaffar-Bandjee MC, El Bock M, Ezzedine K, Vandroux

D. Intensive Care Unit Admission for Pandemic (H1N1) 2009, Reunion Island, 2009. Emerg Infect Dis 2011; 17: 140-1 (IF: 6.751, Rang SIGAPS A).

37. Conte H, Milpied B, Kaloga M, Lalanne N, Belin E, Jouary T, Taïeb A, Ezzedine K. Treatment of pre-ulcerative necrobiosis lipoidica with infliximab. Acta Dermatol Venereol 2011; 91: 587-8 (IF:

3.025, Rang SIGAPS A). 38. Ezzedine K, Solé G, Guillet S, Belin E, Droitcourt C, Jouary T, taieb A. An extraordinary

« sunburn » in a black patient. Br J Dermatol 2011; 164 : 1398-400 (IF: 4.275, Rang SIGAPS A). 39. Kubica E, Ezzedine K, Lalanne N, Dartial Y, Taieb A, Milpied B. Oral alitretinoin in chronic

refractory hand eczema: a “real life” case-series of 12 patients. Eur J Dermatol 2011 ; 21 : 454-6 (IF: 1.990, Rang SIGAPS C).

40. Imbert E, Milpied B, Jouary T, Versapuech J, Goussot JF, Taieb A, Ezzedine K. Penile swelling and ulceration. Acta Derm Venereol 2010; 90: 81-2 (IF: 3.025, Rang SIGAPS A).

41. Ezzedine K, Hercberg S, Malvy D. Antioxidant supplementation and risk of skin cancer. Arch Dermatol 2010; 146: 567-8 (IF: 4.789, Rang SIGAPS A).

42. Ezzedine K, Pistone T, Guir V, Malvy D. Painful Buruli ulcer in a Malian visitor to France. Acta Dermatol Venereol 2010; 90: 424 (IF: 3.025, Rang SIGAPS A).

43. Ezzedine K, Belin E, Pistone T, Milpied B, Jouary T, Taieb A, Longy-Boursier M, Malvy D. Orificial tuberculosis in an immunocompetent careworker. Acta Dermatol Venereol 2010; 90: 552-3 (IF: 3.025, Rang SIGAPS A).

44. Ezzedine K, Hercberg S, Malvy D. Antioxidant supplements and their risk of skin cancer. Clin Dermatol 2010: 28: 695-6 (IF: 2.470, Rang SIGAPS C).

45. Ezzedine K, Wissing KM, Jacobs F, Rodriguez H, Malvy D, Simonart T.Recurrent Scedosporium apiospermum skin infection in a renal transplant recipient. J Eur Acad Dermatol Venereol 2009; 23: 95-6 (IF: 2.826, Rang SIGAPS B).

46. Ezzedine K, Simonart T, Vereecken P, Heenen M. Facial actinic lichen planus following the

Blaschko’s lines: successful treatment with topical 0.1% pimecrolimus cream. J Eur Acad Dermatol Venereol 2009; 23: 458-9 (IF: 2.826, Rang SIGAPS B).

47. Ezzedine K, Pistone T, Marsollier L, Cottin J, Malvy D. Buruli ulcer in a longterm traveller to Senegal. Emerg Infect Dis 2009; 15: 118-9. (IF: 6.751, Rang SIGAPS A).

48. Lalanne N, Ezzedine K, Vergier B, Jouary T. Fatal lymphangiosarcoma revealed by lymphoedema of the goat. Acta Derm Venereol 2009; 3: 318-9 (IF: 3.025, Rang SIGAPS A).

49. Conte H, Ezzedine K, Jouary T, Hubiche T, Taieb A, Milpied B. Eventration caused by

methotrexate in a psoriatic patient. J Eur Acad Dermatol Venereol 2009; 24: 76-7 (IF: 2.826, Rang SIGAPS B).

50. Droitcourt C, Adenis-Lamarre E, Ezzedine K, Taieb A, Jouary T. Blaschkolinear melanocytic congenital nevus. Dermatology 2009; 182-3 (IF: 1.569, Rang SIGAPS C).

51. Ezzedine K, Favier A, Malvy D, Hercberg S. Reply to Schrauzer. J Nutr 2008; 821-2 (IF: 3.875,

Rang SIGAPS B). 52. Ezzedine K, Malvy D, Briançon S, Hercberg S. Reply to Green et al. J Nutr 2008; 138: 979 (IF:

3.875, Rang SIGAPS B). 53. Ezzedine K, Heenen M, Malvy D. Imported cutaneous melioidosis in traveller, Belgium. Emerg

Infect Dis 2007; 13: 946-7 (IF: 6.751, Rang SIGAPS A). 54. Ezzedine K, Rafii N, Heenen M. Lymphomatoid contact dermatitis to an exotic wood: a very

harmful toilet seat. Contact Dermatitis 2007; 57: 128-30 (IF: 3.747, Rang SIGAPS B). 55. Ezzedine K, Malvy D. Recurrent bruising with immunological abnormalities in a 24-year-old

traveller: a new entity? J Eur Acad Dermatol Venereol 2007; 21: 1448-50 (IF: 2.826, Rang

SIGAPS B). 56. Ezzedine K, Dhaussy I, Malvy D, Laporte M, De Dobbeleer G, Heenen M. Long-term prurigo in

a returned expatriate with chronic strongyloidiasis. Int J Dermatol 2006; 45: 1009-10 (IF: 1.312, Rang SIGAPS D).

57. Ezzedine K, Vadoud-Seyedi J, Heenen M. Nicolau syndrome following diclofenac administration. Br J Dermatol 2004; 150: 385-7 (IF: 4.275, Rang SIGAPS A).

REFERENCED PUBLICATIONS (REVIEWS AND EDITORIALS)

1. Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. New discoveries in the

pathogenesis and classification of vitiligo. J Am Acad Dermatol 2017; 77: 1-13. 2. Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Current and emerging

treatments for vitiligo. J Am Acad Dermatol 2017; 77: 17-29. 3. ElBuluk N, Ezzedine K. Quality of Life/Burden of Disease in Vitiligo;

Comorbidities/Systemic Effects. Dermatol Clin 2017 (in press) 4. Eleftheriadou V, Ezzedine K. Portable home phototherapy for vitiligo. Clin Dermatol 2016

(in press). (IF: 2.367, Rang SIGAPS C) 5. Ezzedine K, Silverberg N. A Practical Approach to the Diagnosis and Treatment of Vitiligo in

Children. Pediatrics 2016 (In press, IF: 5.473, Rang SIGAPS A) 6. Picardo M, Dell Anna ML, Ezzedine K, Hamzavi I, Harris JE, Parsad D, Taieb A. Vitiligo. Nature

Reviews Disease Primers 2015; 15011. 7. Ezzedine K, Eleftheriadou V, Whitton M, Nan Geel N. Vitiligo. Lancet 2015; 386: 74-84. (IF:

45.217, Rang SIGAPS A). 8. Hosseini M, Ezzedine K, Taieb A, Rezvani H. Nucleotide excision repair diseases: Oxidative and

energy metabolism as a potential explanation underlying clinical heterogeneity. J Invest Dermatol 2015; 135: 341-51 (in press) (IF: 7.216, Rang SIGAPS A).

9. Taieb A, Alomar A, Böhm M, Dell’Anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y,

Gawkrodger DJ, Jouary J, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M. Guidelines for the Management of Vitiligo: the EDF consensus By the writing group of the Vitiligo European Task Force (VETF) in cooperation with the European Academy of Dermatology and Venereology (EADV) and the Union Européenne des Médecins Spécialistes (UEMS). Br J Dermatol 2013; 168: 5-19 (IF: 4.275, Rang SIGAPS A).

10. Léauté-Labrèze C, Prey S, Ezzedine K. Infantile hemangioma : Part II. Risks, Complications and Treatment. J Eur Acad Dermatol Venereol 2011; 25: 1254-60 (IF: 2.826, Rang SIGAPS B).

11. Léauté-Labrèze C, Prey S, Ezzedine K. Infantile hemangioma : Part I. Pathophysiology, Epidemiology, Clinical features, Life cycle, and Associated structural abnormalities. J Eur Acad Dermatol Venereol 2011; 25: 1245-53 (IF: 2.826, Rang SIGAPS B).

12. Taieb A, Morice F, Jouary T, Ezzedine K, Cario-André M, Gauthier Y. Segmental vitiligo as the

possible expression of cutaneous somatic mosaicism: deriving a new scenario for common nonsegmental vitiligo. Pigment Cell Melanoma Res; 2008; 21: 646-52 (IF: 4.619, Rang SIGAPS

B). 13. Ezzedine K, Pandya A. Time for a patient-oriented outcome in vitiligo: the vitiligo noticeability

scale. Br J Dermatol 2016 (in press) (IF: 4.275, Rang SIGAPS A). 14. Ezzedine K, Barbarot S. Atopic dermatitis and type-1 diabetes mellitus: a true positive

association? Br J Dermatol 2016; 174: 16. (IF: 4.275, Rang SIGAPS A). 15. Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris J, Hamzavi I, Pandya A. Vitiligo is not

a cosmetic disease. J Am Acad Dermatol 2015; 73: 883-5. (IF: 4.449, Rang SIGAPS A). 16. Nijsten T, Apfelbacher C, Gisondi P, Silverberg J, Cohen A, Barbarot S, Wakkee M, Ezzedine K.

Dermatoepidemiology; what's up people? Br J Dermatol 2015; 173: 881-3. (IF: 4.275, Rang SIGAPS A).

17. Ezzedine K, Barbarot S. Can we trust questions about self- and caregivers reported eczema in epidemiologic studies? Br J Dermatol 2015; 173: 1356-7. (IF: 4.275, Rang SIGAPS A).

Page 12 / 12

BOOK CHAPTERS

1. Harris JE, Ezzedine K. Vitiligo. Fitzpatrick's Dermatology in General Medicine 9th

Edition. (in press)

2. Taieb A, Morice-Picard F, Ezzedine K. Genetic disorders of pigmentation. In: Rook's Textbook of Dermatology, Ninth Edition. (T. Burns, S. Breathnach, N. Cox, C. Griffiths, éditeurs), ISBN:

978-1-118-44119-0, Wiley Blackwell Publishing Ltd, 2016. 3. Amiel A, Ezzedine K, Van De Leemput C. Influence du sentiment d’efficacité personnelle et des

conditions matérielles sur les comportements d’évitement de la technologie dans le cadre de la préparation d’un examen de dermatologie. In C Van De Leemput, C Chauvin, & C Hellemans (Eds.), Activités humaines, Technologies et Bien-être: Actes du 7ème colloque de psychologie ergonomique Epique, Paris: Arpege Science Publishing, 2013.

4. Valet F, Ezzedine K, Malvy D, Mary JY, Guinot C. Quality assessment of ordinal scales depicting skin ageing severity. In: Textbook of Aging Skin. (M. A. Farage, K. W. Miller et H. I. Maibach,

éditeurs), ISBN 978-3-540-89655-5 (Print) and ISBN 978-3-540-89656-2 (Electronic publication), Springer-Verlag Berlin Heidelberg, 2010, pp 921-8.

5. Ezzedine K, Lepreux S, Taieb A. Vitiligo and immunodeficiency. Dans : Textbook of Vitiligo. (M.

Picardo, A. Taieb Editeurs), ISBN 978-3-540-69360-4 (Print) and ISBN 978-3-540-69361-1 (Electronic publication), Springer-Verlag Berlin Heidelberg, 2010, pp 91-7.

6. Ezzedine K, Seneschal J, Attili R, Taieb A. Inflammatory vitiligo. Dans : Textbook of Vitiligo. (M.

Picardo, A. Taieb Editeurs), ISBN 978-3-540-69360-4 (Print) and ISBN 978-3-540-69361-1 (Electronic publication), Springer-Verlag Berlin Heidelberg, 2010, pp 99-105.

7. Amiel A, Van De Leemput C, Schietse B, Ezzedine K. Effet de la familiarisation sur l’évolution

des perceptions d’utilité et d’utilisabilité d’une plateforme web de dermatologie. In : N. Pettersen, J.-S. Boudrias & A. Savoie (Eds.), Entre tradition et Innovation, comment transformons-nous l'univers du travail ? Québec: Presses de l'Université du Québec, ISBN 978-2-7605-1530-7, 2008.

8. Amiel A, Van De Leemput C, Schietse B, Ezzedine K. Approche différentielle des performances

lors de tests d’utilisabilité: étude de l’influence de variables culturelles et contextuelles. 5èmes Journées d'Étude en Psychologie Ergonomique – EPIQUE (28-30 Septembre 2008, Nice, France), 2008, Actes du Colloque EPIQUE, Paris: Arpege Science Publishing, 2008, pp.24-31.